Opravil M - Search Results

1

Long-term safety of discontinuation of secondary prophylaxis against Pneumocystis pneumonia: prospective multicentre study.

Zellweger C, Opravil M, Bernasconi E, Cavassini M, Bucher HC, Schiffer V, Wagels T, Flepp M, Rickenbach M, Furrer H; Swiss HIV Cohort Study. Zellweger C, et al. Among authors: opravil m. AIDS. 2004 Oct 21;18(15):2047-53. doi: 10.1097/00002030-200410210-00009. AIDS. 2004. PMID: 15577626

2

Impact of occasional short interruptions of HAART on the progression of HIV infection: results from a cohort study.

Taffé P, Rickenbach M, Hirschel B, Opravil M, Furrer H, Janin P, Bugnon F, Ledergerber B, Wagels T, Sudre P; Swiss HIV Cohort Study. Taffé P, et al. Among authors: opravil m. AIDS. 2002 Mar 29;16(5):747-55. doi: 10.1097/00002030-200203290-00010. AIDS. 2002. PMID: 11964531

3

Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6) /l.

Opravil M, Ledergerber B, Furrer H, Hirschel B, Imhof A, Gallant S, Wagels T, Bernasconi E, Meienberg F, Rickenbach M, Weber R; Swiss HIV Cohort Study. Opravil M, et al. AIDS. 2002 Jul 5;16(10):1371-81. doi: 10.1097/00002030-200207050-00009. AIDS. 2002. PMID: 12131214 Clinical Trial.

4

Meta-analysis of randomized controlled trials of simplified versus continued protease inhibitor-based antiretroviral therapy in HIV-1-infected patients.

Bucher HC, Kofler A, Nüesch R, Young J, Battegay M, Opravil M. Bucher HC, et al. Among authors: opravil m. AIDS. 2003 Nov 21;17(17):2451-9. doi: 10.1097/00002030-200311210-00007. AIDS. 2003. PMID: 14600516

5

Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study.

Wolbers M, Opravil M, von Wyl V, Hirschel B, Furrer H, Cavassini M, Vernazza P, Bernasconi E, Battegay M, Yerly S, Günthard H, Bucher HC; Swiss HIV Cohort Study. Wolbers M, et al. Among authors: opravil m. AIDS. 2007 Oct 18;21(16):2201-7. doi: 10.1097/QAD.0b013e3282efacb1. AIDS. 2007. PMID: 18090047

6

Outcomes of patients on dual-boosted PI regimens: experience of the Swiss HIV cohort study.

Osih RB, Taffé P, Rickenbach M, Gayet-Ageron A, Elzi L, Fux C, Opravil M, Bernasconi E, Schmid P, Günthard HF, Cavassini M; Swiss HIV Cohort Study. Osih RB, et al. Among authors: opravil m. AIDS Res Hum Retroviruses. 2010 Nov;26(11):1239-46. doi: 10.1089/aid.2010.0070. Epub 2010 Oct 7. AIDS Res Hum Retroviruses. 2010. PMID: 20929393 Free PMC article.

7

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.

Fellay J, Marzolini C, Meaden ER, Back DJ, Buclin T, Chave JP, Decosterd LA, Furrer H, Opravil M, Pantaleo G, Retelska D, Ruiz L, Schinkel AH, Vernazza P, Eap CB, Telenti A; Swiss HIV Cohort Study. Fellay J, et al. Among authors: opravil m. Lancet. 2002 Jan 5;359(9300):30-6. doi: 10.1016/S0140-6736(02)07276-8. Lancet. 2002. PMID: 11809184

8

CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.

Kaufmann GR, Perrin L, Pantaleo G, Opravil M, Furrer H, Telenti A, Hirschel B, Ledergerber B, Vernazza P, Bernasconi E, Rickenbach M, Egger M, Battegay M; Swiss HIV Cohort Study Group. Kaufmann GR, et al. Among authors: opravil m. Arch Intern Med. 2003 Oct 13;163(18):2187-95. doi: 10.1001/archinte.163.18.2187. Arch Intern Med. 2003. PMID: 14557216

9

Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy.

Zuber JP, Calmy A, Evison JM, Hasse B, Schiffer V, Wagels T, Nuesch R, Magenta L, Ledergerber B, Jenni R, Speich R, Opravil M; Swiss HIV Cohort Study Group. Zuber JP, et al. Among authors: opravil m. Clin Infect Dis. 2004 Apr 15;38(8):1178-85. doi: 10.1086/383037. Epub 2004 Apr 1. Clin Infect Dis. 2004. PMID: 15095226 Free article.

10

Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudine.

Opravil M, Baumann D, Chave JP, Furrer H, Calmy A, Bernasconi E, Blasko M, Vernazza P, Ledergerber B, Perrin L; Swiss HIV Cohort Study. Opravil M, et al. AIDS. 2004 Nov 5;18(16):2213-5. doi: 10.1097/00002030-200411050-00019. AIDS. 2004. PMID: 15577660 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page